Graham Capital Management’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-7,557
| Closed | -$304K | – | 1184 |
|
|
2024
Q1 | $304K | Sell |
7,557
-6,237
| -45% | -$251K | 0.01% | 758 |
|
|
2023
Q4 | $351K | Buy |
+13,794
| New | +$351K | 0.01% | 658 |
|
|
2023
Q3 | – | Sell |
-25,840
| Closed | -$594K | – | 1156 |
|
|
2023
Q2 | $594K | Buy |
+25,840
| New | +$594K | 0.02% | 494 |
|
|
2022
Q4 | – | Sell |
-101,001
| Closed | -$2.2M | – | 1175 |
|
|
2022
Q3 | $2.2M | Buy |
101,001
+70,238
| +228% | +$1.53M | 0.09% | 192 |
|
|
2022
Q2 | $605K | Buy |
30,763
+17,611
| +134% | +$346K | 0.02% | 600 |
|
|
2022
Q1 | $556K | Buy |
+13,152
| New | +$556K | 0.02% | 509 |
|